Talk:Antiphospholipid syndrome

message: The suggestion is made in this article that the anti phospholipid syndrome is caused by auto antibodies directed against negatively charged phospholipids on the cell/platelet surface. However for almost 15 years it is known that most of the antibodies in this syndrome are directed against proteins that bind negatively charged phospholipids such as prothrombin and beta-2-glycoprotein-1. It is the binding of antibodies to coagulation proteins that causes altered coagulation processes not the binding of antibodies against negatively charged phospholipids. 
I suggest to change the article to correct this misunderstanding. Bio2mancer 24 june 2006.
: JFW | T@lk 20:58, 4 July 2006 (UTC)
thread_title: Rename article

message: We should mention the Sapporo criteria:  . JFW | T@lk 20:58, 4 July 2006 (UTC)
replies: text: And a recent amendment:  . JFW | T@lk 20:59, 4 July 2006 (UTC)
thread_title: Sapporo criteria

message: A recent systematic review on the treatment shows how little we actually know about optimal treatment for this: . JFW | T@lk 21:01, 4 July 2006 (UTC)
thread_title:  Recent review 

message: Since 07 NOV 06...actually making this page very inaccurate.  Please revert back to previous revision before 07 NOV 06.  Tried to get the categories back in.  Hopefully I did it right.eyz 00:10, 21 November 2006 (UTC)
thread_title:  Page has massive changes 

message: Changed a typo (phosphotidylserine to Phosphatidylserine). Rage italic 15:54, 30 March 2007 (UTC)
thread_title:  Typo 

message: Actaully that page is cited and is HONCode certifed.  Very few sites can say that.  It has a bio. upon request.eyz 17:53, 20 May 2007 (UTC)
thread_title:  APSFA Page 

message: Some antibodies are more aborto/thrombogenic than others  JFW | T@lk 06:42, 7 August 2007 (UTC)
thread_title:  Nature of antibodies 

message: - how we diagnose APS. JFW | T@lk 17:29, 1 February 2009 (UTC)
thread_title:  Blood! 

message: Is House MD a reliable and authentic source?  — Preceding unsigned comment added by 93.208.112.205 (talk) 20:15, 21 September 2011 (UTC)
replies: text: Absolutely not. House MD is entertainment, not a reliable source for anything.Wzrd1 (talk) 17:53, 3 February 2012 (UTC)
thread_title:  Source 

message: doi:10.1182/blood-2012-03-378646 the relevance of anti-β2-glycoprotein I antibodies. JFW | T@lk 20:57, 12 July 2012 (UTC)
replies: text: NEJM mechanisms of disease: doi:10.1056/NEJMra1112830 JFW | T@lk 16:09, 14 March 2013 (UTC)
replies: text: Historical review in Br J Haem doi:10.1111/bjh.12848 JFW | T@lk 18:59, 31 March 2014 (UTC)
thread_title:  Review 

message: doi:10.1111/jth.12537 ISTH JFW | T@lk 07:17, 25 May 2014 (UTC)
thread_title:  Laboratory technique 

message: Hi. In the section under the subsubhead 2.1, Lupus anticoagulant, we currently begin the second paragraph thus: "Distinguishing a lupus antibody from a specific coagulation factor inhibitor (eg: Factor VIII)." This is not a sentence and does not make sense on its own. I'd fix it if I was sure how to without distorting the intended sense, but I'm not. (I was tempted to weld it into the next sentence but I'm not 100% certain that works - or was it like a yet another subhead perhaps??) Can someone who can see the sense of the whole thing please sort it out? Thanks and best wishes, DBaK (talk) 11:21, 20 November 2009 (UTC)
replies: text: Fixed, though it's likely the whole section (and many others) should be drastically cut back; encyclopedias don't normally, and shouldn't, give specific diagnostic criteria and protocols - especially when these vary from place to place. Grothmag (talk) 00:13, 9 February 2016 (UTC)
thread_title:  Sentence 

message: I only recently heard of this disease, and had quite a bit of difficulty finding information about it until someone mentioned that it was called by names, including “APLS or APLA in the United States and Hughes Syndrome or Sticky Blood in the UK” (information taken from the APS Foundation of America).  Given the disparity of naming for the condition, I would think it appropriate to include it on various disambiguation pages and/or redirects, as appropriate, to make this information easier to locate.
I’m not familiar enough with Wikipedia’s policies to be comfortable introducing such changes myself, but I welcome others to consider those additions.  Much thanks!
jF 11:48, 3 June 2016 (UTC)
thread_title:  Request to create disambiguation(s) 

message: doi:10.1111/bjh.14632 JFW | T@lk 19:55, 26 March 2017 (UTC)
replies: text: ISTH criteria for laboratory diagnosis: doi:10.1111/jth.13976 JFW | T@lk 21:21, 17 February 2018 (UTC)
replies: text: Something about the DOACs for thromboprophylaxis. doi:10.1111/jth.14017 JFW | T@lk 21:23, 12 April 2018 (UTC)
replies: text: NEJM this week doi:10.1056/NEJMra1705454 JFW | T@lk 11:33, 24 May 2018 (UTC)
thread_title:  New review 

message: A discussion is taking place to address the redirect :New bloody syndrome. The discussion will occur at Wikipedia:Redirects for discussion/Log/2020 August 2#New bloody syndrome until a consensus is reached, and readers of this page are welcome to contribute to the discussion.  Steel1943 (talk) 20:40, 2 August 2020 (UTC)
thread_title:  "New bloody syndrome" listed at [[Wikipedia:Redirects for discussion|Redirects for discussion]] 

message: Recommendations about DOACs doi:10.1111/jth.14935 JFW | T@lk 14:20, 1 September 2020 (UTC)
thread_title:  ISTH SSC